United Kingdom · Question · Written question
UIN 69183
Cancer: Drugs
Introduced
18 July 2025
Last action
4 August 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
4 August 2025
Summary
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 June 2025 to Question 54542 on Drug Prices, how many of the commercial arrangements involving indications-specific pricing were for indications for (a) rare and (b) ult
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
18 July 2025
Written question
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 June 2025 to Question 54542 on Drug Prices, how many of the commercial arrangements involving indications-specific pricing were for indications for (a) rare and (b) ult
Source: Commons
4 August 2025
Answer
Between January 2020 and March 2025, NHS England entered into 62 commercial agreements involving indication-specific pricing for cancer indications. Of these:60 were for indications classified as rare; andof those 60, two were for indications classified a...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-07-18/69183
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1824866
- uk · wq-1824866 · source updated 4 August 2025